Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 945-883-1 | CAS number: 1379424-11-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October-November 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1977
- Qualifier:
- according to guideline
- Guideline:
- other: Standard Operation Procedure of Level Biotechnolocy Inc. (SOP: MP007-04)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Dipentaerythritol hexaesters of 3,5,5-trimethylhexanoic and n-heptanoic acids
- EC Number:
- 945-883-1
- Cas Number:
- 1379424-11-9
- IUPAC Name:
- Dipentaerythritol hexaesters of 3,5,5-trimethylhexanoic and n-heptanoic acids
- Test material form:
- liquid
- Details on test material:
- Colour: Gardner: 0.1
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- Due to migration, the value was transferred to one of the current document's attachments
- Test concentrations with justification for top dose:
- The test article will be dissolved to the stock concentration of 100 mg/mL by ethanol. 5mg/plate of the test item will be used as the highest dose in "dose range finding test". In the groups with metabolic activation, 0.5 mL of metabolic mixture will be used instead of 0.2M phosphate buffer stated in 6.4B of the study report.
According to the result of the dose range finding test, 5 mg/plate was chosen as the highest dose and the other four doses (2.5, 1.25, 0.625, 0.313 mg/plate) were then determined for five Salmonella typhimurium strains. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: The vehicle should not be suspended of chemical reaction with the test article and should be compatible with the survival of the bacteria and the S9 activity.
Controls
- Negative solvent / vehicle controls:
- yes
- Remarks:
- water/ethanol
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- mitomycin C
- other: 2-aminoanthracene, SA
- Details on test system and experimental conditions:
- BACTERIAL SYSTEM:
- Salmonella typhimurium strain TA98, TA100, TA102, TA1535, TA1537
- Bacterial source: Moltox Inc., USA
- The genotype confirmation of bacterial strains was performed according to SOP MP007-04 before testing.
NUMBER OF REPLICATIONS:
- Number of cultures per concentration (single, duplicate, triplicate) : triplicate (all groups including positive, negative, vehicle and five dosage testing groups)
- Number of independent experiments : 1
METHOD OF TREATMENT/ EXPOSURE:
A. The doses used were:
without S9 mix:
TA 98: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (2-nitrofluorene, 1µg/plate)
TA100: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (sodium azide, 1µg/plate)
TA102: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (mitomycin C, 0.2 µg/plate)
TA1535: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (sodium azide, 1µg/plate)
TA1537: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (9-aminoacridine, 50 µg/plate)
without S9 mix:
TA 98: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (2-nitrofluorene, 1µg/plate)
TA100: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (benzo(a)pyrene, 1µg/plate)
TA102: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (2-aminoanthracene, 5 µg/plate)
TA1535: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (2-aminoanthracene, 5 µg/plate)
TA1537: negative control (water), vehicle control (ethanol), test article 5, 2.5, 1.25, 0.625, 0.313 mg/plate, positive control (2-aminoanthracene, 5 µg/plate)
B. Plate incorporaton method was employed and performed as following:
(a) the components were added sequentially according to SOP MP007-04: (1) 0.5 mL of 0.2M Phosphate buffer, pH=7.4 (without S9 metabolic activation), (2) 0.05 mL of each testing concentration of test article, negative, vehicle, or positive control solution, 83) 0.1 mL of overnight culture of the Salmonella typhimurium strains (containing aproximately 1-2x10E9 cells/mL), (4) 2 mL of molten top agar (with 0.5 mM histidine/biotin)
(b) the contents of each tube were mixed and poured onto the surface of minimal glucose agar plates.
(c) when the top agar has been solidified, the plates were inverted and placed in a 37+-1ºC incubator for 48-72 hours. The colonies were then counted.
In the groups with metabolic activation, 0.5 ml of S9 metabolic mixture was used instead of 0.5 mL of 0.2M Phosphate buffer stated in B(a) - Evaluation criteria:
- 1. The raw data of revertant colony values were represented with Mean+-SD.
2. Cell toxicity determination: (A) A cytotoxic effect was concluded when a decrease in revertant colonies over the negative/vehicle control was lower than 0.5-fold, loss of bacterial lawn, or pin colony appeared. (B) Plates would be labeled and excluded from statistics while cytotoxic effect occured.
3. An increase in revertants over the negative control would be as the cut-off between a mutagenic and non-mutagenic response: (A) TA98, TA100 and TA102: more than two-fold increase in revertants over the negative/vehicle control, then the test article would be considered as a potential mutagen. (B) TA1535 and TA1537: more than three-fold increase in revertants over the negative/vehicle control, then the test article would be considered as a potential mutagen.
4. If the test aritlce was considered as a potential mutagen, the raw data would be further analyzed by ANOVA to evaluate the difference between negative/vehicle control group and the test article groups, and p<0.05 indicates the significant difference.
5. If the data showed statistically significant, then to evaluate the dose-related response in the numbers of revertant colonies on the test article group as compared with the vehicle control group. Once dose-related response was confirmed, the test articles would be considered as a mutagen.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Positive controls validity:
- valid
Any other information on results incl. tables
Table 1. Result of genotyping of Salmonella typhimurium strains.
Salmonella typhimurium strains |
Histidine requirement | UV sensitivity | Crystal Violet sensitivity | Ampicilin resistance | Tetracycline resistance | Spontaneous revertants | |
His+ Bio+ Plate |
His- Bio+ Plate |
UV irradiated | Zone of growth inhibition* | Ampicilin plate | Ampicilin tetracycline pate | without S9 | |
TA98 | + | - | - | + | + | - | 32.7 +-3.8 |
TA100 | + | - | - | + | + | - | 158.0 +-4.6 |
TA102 | + | - | + | + | + | + | 463.3 +-15.5 |
TA1535 | + | - | - | + | - | - | 15.3 +-5.1 |
TA1537 | + | - | - | + | - | - | 12.7 +-2.1 |
* remark: +: a clear zone of inhibition appeared around the disc
Table 2. Result of the dose range finding test (in TA100).
dose (mg/plate) | number of revertants / plate (mean+-S.D., n=3) | |
without S9 mixture | ||
negative control (sterile water) | 151.3 +-5.7 | |
positive control (sodium azide, 1µ/plate) | 478.0 +-10.6* | |
vehicle control (ethanol) | 161.3 +-4.5 | |
test article | 5 | 156.7 +-3.1 |
test article | 2.5 | 152.3 +-3.1 |
test article | 1.25 | 157.7 +-14.0 |
test article | 0.625 | 172.3 +-8.4 |
test article | 0.313 | 157.0 +-5.0 |
* remark: more than two-fold increase in revertants over the negative control
Table 3. Result of Bacterial Reverse Mutation Test (5 strains)
group (mg/plate) | Number of revertants / plate (without S9 activator, Mean +- S.D., n=3) | |||||
TA98 | TA100 | TA102 | TA1535 | TA1537 | ||
negative control | 34.3 +-4.0 | 153.0 +-13.0 | 294.7 +-3.1 | 12.0 +-2.6 | 11.0 +-2.0 | |
positive control | 246.0 +-14.4 | 486.7 +-31.9 | 2832.0 +-57.7 | 498.0 +-31.0 | 192.3 +-64.5 | |
vehicle control | 31.3 +-9.0 | 138.0 +-13.2 | 263.3 +-20.0 | 11.7 +-1.5 | 12.3 +-4.0 | |
test article | 5 | 28.7 +-1.5 | 128.7 +-12.7 | 276.0 +-12.2 | 10.0 +-1.0 | 16.0 +-2.6 |
test article | 2.5 | 37.7 +-2.5 | 135.3 +-6.5 | 277.3 +-20.0 | 11.0 +-2.0 | 18.3 +-4.5 |
test article | 1.25 | 37.7 +-2.1 | 126.7 +-17.0 | 302.7 +-17.5 | 10.7 +-3.1 | 12.7 +-2.5 |
test article | 0.625 | 40.7 +-7.2 | 124.3 +-2.5 | 298.0 +-28.2 | 9.0 +-1.0 | 13.3 +-4.2 |
test article | 0.313 | 43.0 +-4.0 | 153.7 +-12.9 | 312.7 +-10.1 | 9.7 +-2.3 | 14.7 +-1.5 |
group (mg/plate) | Number of revertants / plate (with S9 activator, Mean +- S.D., n=3) | |||||
negative control | 38.0 +-2.6 | 111.3 +-6.0 | 323.0 +-43.8a | 13.0 +-1.0 | 12.0 +-2.6 | |
positive control | 806.0 +-24.6* | 291.3 +-33.0* | 670.7 +-7.0* | 213.0 +-67.8* | 337.3 +-36.9* | |
vehicle control | 41.7 +-1.2 | 129.7 +-2.1 | 283.3 +-34.9 | 16.0 +-1.0 | 8.7 +-2.9 | |
test article | 5 | 42.7 +-5.0 | 130.0 +-13.7 | 296.0 +-19.1 | 11.3 +-1.5 | 12.3 +-4.2 |
test article | 2.5 | 39.3 +-10.3 | 110.0 +-5.6 | 283.0 +-15.6a | 13.7 +-2.5 | 13.0 +-1.0 |
test article | 1.25 | 35.7 +-7.6 | 113.7 +-13.6 |
288.7 +-37.2 | 13.0 +-1.0 | 10.3 +-2.5 |
test article | 0.625 | 34.0 +-9.5 | 121.0 +-19.2 | 273.3 +-20.1 | 11.3 +-1.2 | 13.0 +-3.5 |
test article | 0.313 | 41.0 +-8.2 | 120.3 +-5.8 | 301.3 +-14.2 | 9.7 +-1.5 | 12.0 +-3.5 |
Remark:
1. The use of positive control substance for each strain is listed above
2. *: more than two or three-fold increase in revertants over the negative control
3. a: n=2
Applicant's summary and conclusion
- Conclusions:
- According to the numbers of revertant colonies at all the tesing conditions of the five strains used in this study (TA98, TA100, TA102, TA1535, TA1537), the test article did not present genotoxic effect.
- Executive summary:
"Bacterial Reverse Mutation Test" was used in this study to evaluate the genotoxicity of the substance in accordance with OECD Guideline for the testing of chemicals #471 (1997): Bacterial reverse mutation test, and the operation was executed according to the standard operation procedure of Level Biotechnology Inc. (SOP: MP007 -04).
Salmonella typhimurium TA100 was chosen and 5 mg/plate of the test article was used as highest dose in "dose range finding test" to determine the testing dose for "Bacterial Reverse Mutation Test". The result of the "dose range finding test" indicated that the test article showed non-cytotoxic and non-mutagenic effects in Salmonella typhimurium TA100.
According to the result of the "dose range finding test", 5 mg/plate was chosen as the highest dose and the other four doses (2.5, 1.25, 0.625, 0.313 mg/plate) were then determined for five Salmonella typhimurium strains, "Bacterial Reverse Mutation Test". Salmonella typhimurium strains TA98, TA100, TA102, TA1535 and TA1537 were used, and plate incorporation method in the presence and absence of S9 metabolic mixture were applied in this test.
Based on the results of this test, no significant increase in the number of revertant colonies was observed. The test article did not present genotoxic effect at al concentrations of testing strains in the condition of both presence and absence of S9 metabolic mixture. In conclusion, the test article was non-genotoxic in the testing system applied in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.